Hip surgeons and leg length inequality after primary hip replacement.


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 29 5 2018
medline: 4 12 2019
entrez: 30 5 2018
Statut: ppublish

Résumé

This study reports the results of 2 separate surveys of British Hip Society (BHS) members relating to leg length inequality (LLI) after primary total hip replacement (THR). Investigates the members' opinions on the effect of LLI on the outcome of THR and explores the acceptable limits of LLI. Reports on the intraoperative techniques currently used by BHS members to minimise LLI after THR. 97% of all surgeons completing the survey believed that LLI can affect the outcome of THR. All surgeons reported using at least 1 intraoperative technique for assessing leg length with a median of 5 techniques. Over 50% of surgeons use 2 or more tests. 89% of surgeons agreed that 15 mm of LLI after primary uncomplicated THR was always acceptable. 90% of surgeons felt that LLI more than 22.74 mm was never acceptable. Despite the multiple published papers on various methods of assessing leg length intraoperatively, the problem of LLI post THR persists. This study highlights the need for further research to develop a simple intraoperative technique with high accuracy and reproducibility.

Sections du résumé

BACKGROUND: UNASSIGNED
This study reports the results of 2 separate surveys of British Hip Society (BHS) members relating to leg length inequality (LLI) after primary total hip replacement (THR).
SURVEY 1: UNASSIGNED
Investigates the members' opinions on the effect of LLI on the outcome of THR and explores the acceptable limits of LLI.
SURVEY 2: UNASSIGNED
Reports on the intraoperative techniques currently used by BHS members to minimise LLI after THR.
RESULTS - SURVEY 1: UNASSIGNED
97% of all surgeons completing the survey believed that LLI can affect the outcome of THR.
RESULTS - SURVEY 2: UNASSIGNED
All surgeons reported using at least 1 intraoperative technique for assessing leg length with a median of 5 techniques. Over 50% of surgeons use 2 or more tests.
CONCLUSION - SURVEY 1: UNASSIGNED
89% of surgeons agreed that 15 mm of LLI after primary uncomplicated THR was always acceptable. 90% of surgeons felt that LLI more than 22.74 mm was never acceptable.
CONCLUSION - SURVEY 2: UNASSIGNED
Despite the multiple published papers on various methods of assessing leg length intraoperatively, the problem of LLI post THR persists. This study highlights the need for further research to develop a simple intraoperative technique with high accuracy and reproducibility.

Identifiants

pubmed: 29808725
doi: 10.1177/1120700018777858
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-108

Auteurs

Faye A Loughenbury (FA)

1 NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK.

Anthony B McWilliams (AB)

1 NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK.
2 Barnsley Hospitals NHS Trust, Barnsley, UK.

Todd D Stewart (TD)

1 NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK.
3 Leeds Institute for Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, UK.

Anthony C Redmond (AC)

1 NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK.
3 Leeds Institute for Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, UK.

Martin H Stone (MH)

1 NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK.
3 Leeds Institute for Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH